ArticleJournal of addiction medicine
Hospital Readmission and Mortality Among Alcohol-related Cancer Survivors With an Alcohol Use Disorder Diagnosis.
Article in Journal of addiction medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
objectivesUnhealthy alcohol use, which includes alcohol use disorder (AUD), is common among cancer survivors and can lead to negative health outcomes. Prior research found that an AUD diagnosis is associated with hospital readmission up to 180 days after discharge among alcohol-related cancer survivors. This study investigates whether AUD diagnosis is associated with hospital readmission 30 and 90 days after discharge and in-hospital mortality.
methodsWe conducted a retrospective cohort study using the all-payer Nationwide Readmissions Database (NRD) from 2017 to 2020. We identified hospitalized adults with a history of alcohol-related cancer and stratified them by AUD diagnosis status. We applied 1:1 propensity score matching to balance measured demographic and clinical characteristics. We used logistic regression models to assess the association between AUD diagnosis and 30-day and 90-day readmission and mortality and Cox proportional hazards models to estimate time to readmission and mortality.
resultsAmong 70,731 alcohol-related cancer survivors, 3067 (4.34%) had an AUD diagnosis. In the matched cohort (n=2916), AUD diagnosis was significantly associated with increased odds of 90-day readmission (odds ratio [OR], 1.150; 95% CI, 1.021-1.295) but was not significantly associated with 30-day readmission (OR, 1.102; 95% CI, 0.888-1.368) or mortality (OR, 1.102; 95% CI, 0.888-1.368).
conclusionsHospitalized cancer survivors with AUD are at a higher risk for 90-day readmission. Findings from this and prior studies underscore the need for targeted postdischarge interventions to reduce the risk of long-term readmission in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.